Disclosure Of Voting Results
Find enclosed herewith details of Voting Results of 3rd AGM of the Company27-09-2018
27-09-2018
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 3rd Annual General Meeting (AGM) of the Members of the Company held on Tuesday, September 25, 2018 at the Registered Office of the Company C-105, MIDC Mahad, Dist- Raigad, Mahad - 402 309.26-09-2018
Fixes Book Closure for AGM (Cut-off date for e-voting)
Lasa Supergenerics Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 19, 2018 to September 25, 2018 (both days inclusive) for the purpose of 3rd Annual General Meeting (AGM) of the Company to be held on September 25, 2018.14-09-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of the Notice of 3rd Annual General Meeting (AGM), remote e-voting and book closure information.04-09-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, please find enclosed herewith copy of newspaper advertisements.21-08-2018
Outcome of Board Meeting (AGM on Sep 25, 2018)
Lasa Supergenerics Ltd has informed BSE about Outcome of Board Meeting held on August 13, 2018.14-08-2018
Outcome of Board Meeting
1) Approved Statement of Unaudited Financial Results for the Quarter ended June 30, 2018 along with Limited Review Report. 2) Considered and adopted Re-stated Financial Statement as on March 31, 2018. 3) Considered and approved appointment of Mr. Ravi Shankar Kabra as CFO of the Company with immediate effect i.e August 13, 2018. 4) Considered and approved appointment of Mr. Mithun Jadhav (DIN: 08181048) as Additional Director in the...13-08-2018
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Along With Limited Review Report For The Quarter Ended June 30, 2018 And Closure Of Trading Window
LASA SUPERGENERICS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2018 ,inter alias, to consider and approve Unaudited Financial Results of the Company along with Limited Review Report for the Quarter ended June 30, 2018, and/or to discuss any other business/matter with the permission of the Chairman....02-08-2018
Shareholding for the Period Ended June 30, 2018
Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here21-07-2018
Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nidhi KulshresthaDesignation :- Company Secretary and Compliance Officer17-07-2018